Although
statins are highly effective for reducing
cardiovascular disease events, prior studies demonstrate their significant underuse in the US population, including among those with known atherosclerotic disease. It is unknown whether this finding applies to the subset of patients who present for
outpatient surgery, as such patients would be expected to have recent exposures to healthcare providers during the preoperative referral period. The primary aim of this manuscript was to ascertain the prevalence of
statin underuse and associated risk-factors for such underuse among ambulatory surgical patients with documented atherosclerotic
cardiovascular disease. This was a retrospective observational study of a random sample of 600 patients ages 40-75 years presenting for
ambulatory surgery within a 6-month period in 2016, at one of three ambulatory surgical centers affiliated with a large, tertiary care hospital. Compilation and analysis of data occurred in 2018-2019. Of the 600 subjects, 117 (19.5%) had documented atherosclerotic
cardiovascular disease. Within this high-risk group, only 71 (60.7%) carried a prescription for any
statin, and only 30 (25.6%) were prescribed a recommended high intensity
statin dose for
secondary prevention. In a multivariable logistic regression analysis, older age, male sex, and treatment for
hypertension were positively associated with
statin use. In conclusion,
statin underuse among ambulatory surgical patients is common and mirrors what has been observed in non-surgical populations. Future trials are needed to investigate the possible role of surgical teams to promote guideline-based
statin therapy, including the role of preoperative screening interventions to impact long term cardiovascular morbidity and mortality.